Ignite Creation Date:
2024-05-05 @ 11:22 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01318954
Status:
COMPLETED
Last Update Posted:
2015-10-29
First Post:
2009-09-28
Brief Title:
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
Sponsor:
Rohr and Columbo Asthma Allergy and Immunology Specialists PC
Organization:
Rohr and Columbo Asthma Allergy and Immunology Specialists PC
Study Overview
Official Title:
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy allergy shots The investigators hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None